Theravance Biopharma, Inc. earnings per share and revenue

TBPH earnings per share for the last quarter are -0.31 USD whereas the estimation was -0.20 USD which accounts for -55.70% surprise. Company revenue for the same period amounts to 18.75 M USD despite the estimated figure of 17.03 M USD. Estimated earnings per share for the next quarter are 0.10 USD, and revenue is expected to reach 15.50 M USD. Also watch annual changes over time to get a bigger picture of TBPH earnings per share and revenue dynamics.